Skip to main content
. 2023 Sep 12;12:e85867. doi: 10.7554/eLife.85867

Figure 7. Genotype and antimicrobial resistance (AMR) prevalence rates estimated for Nigeria from different data sources.

Figure 7.

Data are shown only for source labs with N≥10 isolates from which to estimate prevalence. (a) Genotype prevalence and (b) AMR prevalence, using all available isolates per lab, 2010–2020. Lines show 95% confidence interval for each proportion (prevalence) estimate. Red indicates estimates based on data from individual labs, black indicates pooled estimates (i.e. from all labs), as per inset legend. (c) Annual genotype frequencies. Bars are coloured by genotype as per inset legend. Lab abbreviations are shown in y-axis labels for panels (a–b). MDR, multidrug resistant; XDR, extensively drug resistant; CipNS, ciprofloxacin non-susceptible; CipR, ciprofloxacin resistant; CefR, ceftriaxone resistant; AziR, azithromycin resistant. See Supplementary file 9 for three-letter laboratory code master list.